Lars-Erik Peters

This inventor holds 6 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Qiagen North American Holdings, Inc, Eppendorf Ag, Qiagen Gmbh. Active years: 2003-2012.

USPTO Granted Patents = 6 (Patent Applications = 3)

% Patents Active = 33.3

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 89(Granted Patents)

Company Filing History:

3 out of 12

Qiagen North American Holdings, Inc

Years Active: 2003-2012

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8192960 - One component and two component DNA Pol III replicases and uses thereof (2012-06-05),

2. 8183023 - [object Object] (2012-05-22),

3. 7932059 - dUTP-based compositions for reducing primer-aggregate formations during nucleic acid amplification (2011-04-26),

4. 7364898 - Customized micro-array construction and its use for target molecule detection (2008-04-29),

5. 7323310 - Methods and compositions for RNA amplification and detection using an RNA-dependent RNA-polymerase (2008-01-29),

6. 6667165 - Method and compositions for reversible inhibition of thermostable polymerases (2003-12-23),

Title: The Innovative Mind of Lars-Erik Peters: A Leader in DNA Polymerase Development

Introduction

Lars-Erik Peters, based in Lafayette, Colorado, has made significant contributions to the field of molecular biology through his innovations in DNA polymerase technology. With a total of six patents to his name, Peters is recognized for his groundbreaking work that has implications in nucleic acid amplification and sequencing.

Latest Patents

Among his latest inventions are the "One component and two component DNA Pol III replicases and uses thereof" and a thermophilic polymerase with a primer extension rate exceeding 35 bases per second. The former offers novel DNA polymerases and kits for nucleic amplification and sequencing, while the latter focuses on a polymerase that operates effectively at high temperatures, demonstrating superior efficiency in DNA replication assays. These advancements highlight his role in enhancing the precision and effectiveness of genetic research.

Career Highlights

Lars-Erik Peters has had a notable career, having worked with companies such as Qiagen North American Holdings, Inc. and Eppendorf AG. His experience in these leading biotechnology firms has contributed to the development of innovative tools that are widely used in genetic research and diagnostic applications.

Collaborations

Throughout his career, Peters has collaborated with accomplished professionals, including coworkers Michael J. Domanico and Sven Buelow. These collaborations have fostered an environment of creativity and innovation, leading to successful projects that push the boundaries of current scientific understanding.

Conclusion

In conclusion, Lars-Erik Peters stands out as a prominent inventor in the field of DNA polymerases. His six patents not only showcase his innovative spirit but also reflect his commitment to advancing molecular biology. With a strong background in leading biotechnology companies and fruitful collaborations, Peters continues to influence the future of genetic research.